Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 91. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_619ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.001 MOI77% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_620ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.01 MOI77% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_621ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.1 MOI52% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_622ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.5 MOI48% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_623ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay1 MOI40% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_624ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.001 MOI60% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_625ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.01 MOI50% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_626ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.1 MOI48% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_627ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.5 MOI40% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_628ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay1 MOI38% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_629ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.001 MOI120% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_630ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.01 MOI110% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_631ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.1 MOI60% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_632ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.5 MOI40% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_633ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay1 MOI30% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_634ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.001 MOI110% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_635ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.01 MOI70% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_636ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.1 MOI58% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_637ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.5 MOI25% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_638ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay1 MOI25% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_639ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.001 MOI105% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_640ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.01 MOI107% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_641ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.1 MOI90% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_642ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.5 MOI70% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_643ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay1 MOI61% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_644ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.001 MOI90% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_645ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.01 MOI93% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_646ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.1 MOI87% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_647ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.5 MOI58% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_648ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay1 MOI59% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_679ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.001 MOI120% cancer cell viability (calculated as relative to mock-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_680ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.01 MOI105% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_681ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.1 MOI100% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_682ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.5 MOI70% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_683ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay1 MOI50% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_684ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.001 MOI120% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_685ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.01 MOI105% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_686ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.1 MOI77% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_687ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.5 MOI50% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_688ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay1 MOI30% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_689ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.001 MOI120% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_690ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.01 MOI126% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_691ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.1 MOI92% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_692ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.5 MOI72% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_693ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay1 MOI61% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_1437AdenovirusZD-55-IL-18DNAAdenoviridaeNoneYesNoVirus expressing IL-18 geneShanghai cell collectionHuman melanoma cell lineA375NANACrystal violet staining0.01 MOICell survival observerdNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19498459
OV_1438AdenovirusZD-55-IL-18DNAAdenoviridaeNoneYesNoVirus expressing IL-18 geneShanghai cell collectionHuman melanoma cell lineA375NANACrystal violet staining0.1 MOICell survival observerdNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19498459
OV_1439AdenovirusZD-55-IL-18DNAAdenoviridaeNoneYesNoVirus expressing IL-18 geneShanghai cell collectionHuman melanoma cell lineA375NANACrystal violet staining1 MOICell survival observerdNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19498459
OV_1440AdenovirusZD-55-IL-18DNAAdenoviridaeNoneYesNoVirus expressing IL-18 geneShanghai cell collectionHuman melanoma cell lineA375NANACrystal violet staining10 MOI100% cell deathNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19498459
OV_1441AdenovirusZD-55-IL-18DNAAdenoviridaeNoneYesNoVirus expressing IL-18 geneShanghai cell collectionHuman melanoma cell lineA375NANACrystal violet staining100 MOI100% cell deathNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19498459
OV_4275AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman melanoma cell lineB164000 cells per wellNAMTT assay10 pfu2.19 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_5092Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.001 MOI70% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5093Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.01 MOI50% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5094Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.1 MOI20% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5095Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5096Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.001 MOI70% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5097Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.01 MOI60% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5098Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay0.1 MOI40% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5099Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineHS294T1.0E+4 cells per wellNAMTS assay1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5100Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.001 MOI60% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5101Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.01 MOI30% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5102Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5103Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay1 MOI100% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5104Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.001 MOI80% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5105Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.01 MOI30% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5106Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay0.1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5107Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineA20581.0E+4 cells per wellNAMTS assay1 MOI100% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5116Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.001 MOI60% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5117Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.01 MOI40% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5118Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.1 MOI10% cell viabilityNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5119Vaccinia virusvvdd-tdTomato-hDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of human DAIYesNoVirus expressing human DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay1 MOI100% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5120Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.001 MOI90% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5121Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.01 MOI70% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5122Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay0.1 MOI20% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5123Vaccinia virusvvdd-tdTomato-mDAIDNAPoxviridaeDeletion of tk gene and vaccinia growth gene and addition of murine DAIYesNoVirus expressing murine DAI geneATCCHuman melanoma cell lineSK-MEL-21.0E+4 cells per wellNAMTS assay1 MOI100% cell killingNoNoNA No responseNANAInduction of Immunogenic gene such as T cell activationNA27626058
OV_5599Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineSK-MEL-280% confluencyNAMTT assay8 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5600Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineSKMEL-380% confluencyNAMTT assay2 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5601Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineSKMEL-580% confluencyNAMTT assay4 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5602Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineA37580% confluencyNAMTT assay37 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5603Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineMALME-3M80% confluencyNAMTT assay778 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5604Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineHT14480% confluencyNAMTT assay28 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5818Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineSK-MEL-280% confluencyNANA8 pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5819Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineSKMEL-380% confluencyNANA2 pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5820Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineSKMEL-580% confluencyNANA4 pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5821Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineA37580% confluencyNANA37 pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5822Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineMALME-3M80% confluencyNANA778 pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5823Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman melanoma cell lineHT14480% confluencyNANA28 pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5910Newcastle disease virusNDV-B1RNAParamyxoviridaeNoneYesNoNoATCCHuman melanoma cell lineSK MEL-25E+5 pfuNALDH release assay0.1 MOI100% cell killing observed after 3 daysNoNoNA NANAVirus induced IFN-gamma productionNAUS10035984
OV_5911Newcastle disease virusNDV-B1RNAParamyxoviridaeNoneYesNoNoATCCHuman melanoma cell lineB16-F105E+5 pfuNALDH release assay0.1 MOI40% cell killing after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984
OV_5912Newcastle disease virusNDV-F3aaRNAParamyxoviridaeVirus expressing NS1 proteinYesNoNoATCCHuman melanoma cell lineSK MEL-25E+5 pfuNALDH release assay0.1 MOI100% cell killing observed after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984
OV_5913Newcastle disease virusNDV-F3aaRNAParamyxoviridaeVirus expressing NS1 proteinYesNoNoATCCHuman melanoma cell lineB16-F105E+5 pfuNALDH release assay0.1 MOI30% cell killing after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984